文献速递中毒与环境急症重症综合管理与镇静镇痛

哌仑帕奈过量:美国中毒中心的临床效应与结局

Clinical effects and outcomes of perampanel overdoses reported to U.S. poison centers.
PubMed 文献 · Clin Toxicol (Phila) · 2021-07-19
一句话结论哌仑帕奈过量以嗜睡、激越、共济失调和意识模糊为主,近19%出现中度/重度效应,但病例数不足以确定分诊剂量阈值。

该研究为回顾性观察性研究,分析2014年1月至2019年12月美国国家中毒数据系统(NPDS)中所有单种物质哌仑帕奈摄入病例,共138例。中位年龄20岁(IQR 10-38),男性68例(49.3%)。暴露原因最常见为治疗错误(80例,58.0%),其次为探索性摄入(24例,17.4%)和自杀性摄入(14例,10.1%)。6例(4.3%)出现重度效应,20例(14.5%)中度,32例(23.2%)轻度,22例(15.9%)无效应,54例(39.1%)未随访。近半数病例在家处理;在医疗机构(n=72)中,多数治疗/评估后离院(31例,43.1%),其次收入非重症病房(20例,27.8%)和重症病房(13例,18.1%)。最常见症状为嗜睡(27例,19.6%)、激越(20例,14.5%)、共济失调(13例,9.4%)和意识模糊(12例,8.7%)。医疗机构最常见治疗为静脉输液(22例,30.6%),其次为苯二氮䓬类(14例,19.4%)和其他类型镇静(9例,12.5%)。病例数太少,无法确定分诊用的剂量截断值。

要点

  • 138例单种哌仑帕奈摄入中,近19%出现中度/重度效应,近4%接受了可能救命的干预。
  • 最常见症状为嗜睡(19.6%)、激越(14.5%)、共济失调(9.4%)和意识模糊(8.7%)。
  • 暴露原因以治疗错误为主(58.0%),其次为探索性摄入(17.4%)和自杀性摄入(10.1%)。
  • 医疗机构内最常见治疗为静脉输液(30.6%),其次为苯二氮䓬类(19.4%)和其他镇静(12.5%)。
  • 病例数太少,无法确定用于分诊急性意外摄入的剂量截断值。

适用人群与场景

  • 2014年1月至2019年12月向美国国家中毒数据系统(NPDS)报告的所有单种物质哌仑帕奈摄入病例,共138例,中位年龄20岁(IQR 10-38),男性68例(49.3%)。
  • 暴露原因包括治疗错误(80例,58.0%)、探索性摄入(24例,17.4%)、自杀性摄入(14例,10.1%)等。
  • 近半数病例在家处理;在医疗机构者共72例,其中多数治疗/评估后离院(31例,43.1%),收入非重症病房20例(27.8%),收入重症病房13例(18.1%)。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 在医疗机构(n=72)中最常见治疗为静脉输液(22例,30.6%),其次为苯二氮䓬类(14例,19.4%),再次为其他类型镇静(9例,12.5%)。
  • 原文未提及具体药物剂量、给药途径、频次或目标值。

红旗征与不能漏的情况

  • 出现重度效应者6例(4.3%),中度效应者20例(14.5%),近4%患者接受了可能救命的干预。
  • 最常见症状为嗜睡(27例,19.6%)、激越(20例,14.5%)、共济失调(13例,9.4%)和意识模糊(12例,8.7%)。

研究设计与关键结果

  • 研究类型为回顾性观察性研究,数据来源于美国国家中毒数据系统(NPDS),纳入2014年1月至2019年12月所有单种物质哌仑帕奈摄入病例,共138例。
  • 主要结局为描述临床效应:6例(4.3%)重度效应,20例(14.5%)中度效应,32例(23.2%)轻度效应,22例(15.9%)无效应,54例(39.1%)未随访。
  • 在医疗机构(n=72)中,31例(43.1%)治疗/评估后离院,20例(27.8%)收入非重症病房,13例(18.1%)收入重症病房。
  • 最常见症状为嗜睡(27例,19.6%)、激越(20例,14.5%)、共济失调(13例,9.4%)、意识模糊(12例,8.7%)。
  • 医疗机构最常见治疗为静脉输液(22例,30.6%)、苯二氮䓬类(14例,19.4%)、其他类型镇静(9例,12.5%)。
  • 病例数太少,无法确定用于分诊急性意外摄入的剂量截断值。

证据类型、等级与局限

  • 证据类型为回顾性观察性研究,基于美国国家中毒数据系统(NPDS)的自愿报告数据。
  • 局限包括:病例数少(138例),54例(39.1%)未随访,数据为自愿报告可能存在报告偏倚,病例数不足以确定剂量-效应关系或分诊阈值。

对床旁实践的改变

  • 哌仑帕奈过量患者应警惕嗜睡、激越、共济失调和意识模糊,近19%出现中度/重度效应,近4%需可能救命的干预。
  • 医疗机构内处理以支持治疗为主,最常见为静脉输液和苯二氮䓬类,但原文未给出具体剂量方案。
  • 由于病例数太少,无法确定分诊用的剂量截断值,不能依据摄入剂量决定是否留观或收入ICU。
  • 近半数病例在家处理,但原文未说明哪些患者适合在家观察。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

INTRODUCTION: Perampanel is indicated for partial onset seizures in children and adults. The mechanism is unique among antiepileptic agents as it inhibits glutamate activity on AMPA receptors. Currently, there are few published case reports describing overdose.

METHODS: This is a retrospective observational study of all single substance perampanel ingestions from January 2014 to December 2019 reported to the national poison data system (NPDS). The primary outcome is to describe the clinical effects of perampanel exposures. Secondary outcomes include evaluation of management and investigation of a dose-effect relationship for the purpose of triaging acute unintentional exposures.

RESULTS: A total of 138 exposures were reported to NPDS since the release of the agent. Median age was 20 years (IQR 10-38) with 68 (49.3%) males. The reason for exposure was most commonly therapeutic error (80, 58.0%), followed by exploratory ingestion (24, 17.4%), and suicidal ingestion (14, 10.1%). A total of six (4.3%) patients developed major effects, 20 (14.5%) moderate, 32 (23.2%) minor effects and 22 (15.9%) no effect. An additional 54 (39.1%) cases were not followed. Almost half of cases were managed at home. Of those that were in a healthcare facility (HCF) (n = 72), most were treated/evaluated and released (31, 43.1%), followed by admission to a non-critical care unit (20, 27.8%), and critical care unit (13, 18.1%). Most frequently reported symptoms were drowsiness (27, 19.6%), agitation (20, 14.5%), ataxia (13, 9.4%), and confusion (12, 8.7%). The most common therapies provided in a HCF were intravenous fluids (22,30.6%), followed by benzodiazepines (14, 19.4%), then other types of sedation (9, 12.5%). There were too few cases to determine a dose cut off for triaging.

CONCLUSIONS: While drowsiness, agitation, ataxia, and confusion were the most often reported symptoms, close to 19% developed moderate/major effects and almost 4% of patients received potentially life-saving interventions.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Minhaj FS, Leonard JB, Klein-Schwartz W, et al. Clinical effects and outcomes of perampanel overdoses reported to U.S. poison centers. Clin Toxicol (Phila). 2021. PMID: 34275405. doi:10.1080/15563650.2021.1945083

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。